MedPath

A prophylactic interventional study to determine the possible protective effect of Siddha Polyherbal formulation Kabasura Kudineer against the COVID 19 onintermittent, month-long consumption by public with close contacts to COVID patients and frontline workers in Tamil Nadu, India

Phase 2
Completed
Registration Number
CTRI/2020/06/025769
Lead Sponsor
ational institute of Siddha Ministry of AYUSH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20462
Inclusion Criteria

All the willing frontline health workers, police personnel and other public servants inclusive of those with direct / primary contacts with COVID positives (High risk and moderate risk exposures).

Exclusion Criteria

Not willing to sign informed consent.

Subjects taking Steroid treatment and or any kind of immunosuppressive therapy

Subjects participating in any other clinical study or having participated in any other study 1 month prior to screening in the present study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of participants protected during the outbreak of COVID 19 compared between the Kabasura Kudineer taken and Standard of Care taken groupsTimepoint: Assessment will be done at Baseline and 30th day from the start of Prophylactic intervention.
Secondary Outcome Measures
NameTimeMethod
General and specific health status as assessed. <br/ ><br>â?? Immune Status and Function as assessed by ISQ <br/ ><br>â?? Progression of disease in the participants who turned COVID 19 positiveTimepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath